IL6 and neoplasm: We found that humanization of the IL-6 locus significantly improved human hematopoietic engraftment of MISTRG6 mice compared with prior models, allowing efficient modeling of individual patients’ tumor-immune interactions using low numbers of HSPCs obtained prospectively from bone marrow (BM) aspirates.